Search

everythinglearnresearchcommunity

for

Search:↓

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Ascorbic acid derivatives improve drug delivery systems.

TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

New compounds may soon be tested to treat excessive hair growth in women.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Four-amino acid part makes enzyme sensitive to finasteride.

A new method was created to analyze certain chemicals in the urine of alopecia areata patients, revealing they have higher metanephrine content. This method can also be used for other related diseases.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The treatment helped promote hair growth in men with androgenetic alopecia.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.